register

News & Trends - MedTech & Diagnostics

Baxter to expand local manufacturing with NSW Government investment

Health Industry Hub | May 12, 2021 |

MedTech News: Baxter Healthcare, a local manufacturer of Australian made medical products, announced a major expansion of its Western Sydney advanced manufacturing facility.

Premier Gladys Berejiklian said the $250 million program from Investment NSW was an opportunity for the state to invest in its future prosperity by nurturing industries, technology and stimulating job creation.

As Australia’s only local manufacturing facility for IV medical fluids, Baxter will expand its manufacturing operations in Old Toongabbie, NSW, to strengthen Australia’s national medical supply chain and exports of Australian Made medicines to the Oceania Region.

With the funding support from NSW Government’s Job Plus program, Baxter will install a new additional production filling line for its intravenous (IV) medical fluids.

The expanded facility is expected to create approximately 80 new advanced manufacturing jobs, in addition to jobs created due to construction.

General Manager for Baxter Australia & New Zealand, Steven Flynn said “Baxter is proud to partner with the NSW Government to invest in our modern manufacturing operations in Western Sydney and create jobs in the local medtech sector.

“This major expansion of Baxter’s medical manufacturing facility will help to strengthen our national supply chain resilience and support continued export growth of Australian Made medicines.

“Baxter intravenous (IV) medicines are the backbone of medication delivery in the ICU, oncology wards, emergency rooms and operating theatres across Australia and the South Pacific.”

“As Australia’s only local manufacturer of IV medical fluids, Baxter is committed to supporting our hospitals and healthcare professionals with reliable supply of medicines during the pandemic and beyond,” Mr Flynn added.

Minister for Jobs, Investment, Tourism and Western Sydney Stuart Ayres said supporting the growth of medical technology and healthcare innovation protected lives as well as the economy.

“The pandemic put a spotlight on the value of these high-growth, essential industries and backing their growth is crucial to ensure our economy is fuelled by sustainable, knowledge-based jobs that are here for the long run,” Mr Ayres stated.


Medical

NSW Health to settle class action

NSW Health to settle ‘largest’ class action

Health Industry Hub | April 29, 2024 |

A class action alleging NSW Health underpaid clinicians has settled after the department agreed to a payout of nearly a […]

More


News & Trends - Pharmaceuticals

Lilly's first-in-class therapy PBS listed for early breast cancer after 15-year gap

Lilly’s first-in-class therapy PBS listed for early breast cancer after 15-year gap

Health Industry Hub | April 29, 2024 |

Pharma News: Australians diagnosed with early-stage breast cancer, particularly those at high risk of recurrence, will gain access to the […]

More


News & Trends - Pharmaceuticals

AstraZeneza secures four PBAC nods in oncology, diabetes, kidney and rare diseases

AstraZeneza secures four PBAC nods in oncology, diabetes, kidney and rare diseases

Health Industry Hub | April 29, 2024 |

Pharma News: AstraZeneca has scored four positive Pharmaceutical Benefits Advisory Committee (PBAC) recommendations following the March meeting. These recommendations, spanning […]

More


News & Trends - Pharmaceuticals

PBAC recommendation to reshape prescribing in heart failure

PBAC recommendation to reshape prescribing in heart failure

Health Industry Hub | April 29, 2024 |

Pharma News: Aligned with the government’s Scope of Practice Review, the Pharmaceutical Benefits Advisory Committee (PBAC) has made a practice-changing […]

More


This content is copyright protected. Please subscribe to gain access.